The production of recombinant human erythropoietin.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biotechnology Annual Review

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1387-2656(08)70055-3PMID 9704092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.

  1994cited by this paper
• Structures of mucin-type sugar chains on human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells.

  1993cited by this paper
• Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.

  1991cited by this paper
• Structures and functional roles of the sugar chains of human erythropoietins.

  1991cited by this paper
• Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N‐glycolylneuraminic acid

  1990cited by this paper
• Erythropoietin treatment of anemia associated with multiple myeloma.

  1990cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant Chinese hamster ovary cells.

  1990cited by this paper
• Survival of recombinant erythropoietin in the circulation: the role of carbohydrates.

  1989cited by this paper
• Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

  1989cited by this paper
• Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells.

  1989cited by this paper
• Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry.

  1988cited by this paper
• Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins.

  1988cited by this paper
• Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function.

  1988cited by this paper
• Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells.

  1988cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin.

  1987cited by this paper
• Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA.

  1987cited by this paper
• Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.

  1986cited by this paper
• Murine erythropoietin gene: cloning, expression, and human gene homology

  1986cited by this paper
• Structural characterization of human erythropoietin.

  1986cited by this paper
• Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene

  1986cited by this paper
• Isolation and characterization of genomic and cDNA clones of human erythropoietin

  1985cited by this paper
• Cloning and expression of the human erythropoietin gene.

  1985cited by this paper
• Analysis in Cos-1 cells of processing and polyadenylation signals by using derivatives of the herpes simplex virus type 1 thymidine kinase gene

  1983cited by this paper
• Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences

  1981cited by this paper
• Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.

  1980cited by this paper
• Effect of Erythropoietin Therapy on the Red Cell Volume of Uraemic and Non‐uraemic Rats

  1977cited by this paper
• Purification of human erythropoietin.

  1977cited by this paper
• Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

  1976cited by this paper
• On the mechanism of erythropoietin-induced differentiation. 13. The role of sialic acid in erythropoietin action.

  1974cited by this paper
• The role of sialic acid in determining the survival of glycoproteins in the circulation.

  1971cited by this paper
• [The role of the kidney in erythropoiesis].

  1960cited by this paper
• Role of the Kidney in Erythropoiesis

  1957cited by this paper
• Erythropoietic Stimulation Induced by “Anemic“ Serum.∗

  1953cited by this paper

• Antibody Productivity of CHO Cells is Altered by ER Stress Tolerance of the Host Cell

  2024cites this paper
• Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti‐doping application

  2022cites this paper
• Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

  2022cites this paper
• The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review

  2022cites this paper
• Carbohydrate Based Therapeutics

  2021cites this paper
• Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research

  2020cites this paper
• DEVELOPMENT OF PROTEIN DRUGS

  2020cites this paper
• Production and Purification of A Cell-Penetrating Peptide-Erythropoietin Fusion Protein and Optimization of an in Vitro Blood-Brain Barrier Model for Central Nervous System Drug Delivery

  2020cites this paper
• Recombinant Human Erythropoietin : Benefits in Veterinary Medicine

  2019influential citation
• Cost-effective indirect ELISA method for determination of recombinant human erythropoietin in production streams

  2019cites this paper
• Medicina del deporte

  2019cites this paper
• Molecular Design, Expression and Evaluation of PASylated Human Recombinant Erythropoietin with Enhanced Functional Properties

  2017cites this paper
• Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity.

  2015cites this paper
• Influencia de administración de eritropoyetina humana recombinante en el rendimiento físico: un estudio de revisión

  2014cites this paper
• WITHDRAWN: A review on pharmacological use of recombinant human erythropoietin in renal and non-renal anemia and other potential applications in clinical practice

  2014cites this paper
• Isolation, enrichment, and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry.

  2014cites this paper
• Erythropoietin use and abuse

  2012cites this paper
• Expression, Identification, and Bioactivity of Recombinant Human Erythropoietin from LMH/2A (Leghorn Male Hepatoma)Cell Line

  2011influential citation
• Expression and Secretion of the Human Erythropoietin Using an Optimized cbh1 Promoter and the Native CBH I Signal Sequence in the Industrial Fungus Trichoderma reesei

  2011cites this paper
• Validation of model virus removal and inactivation capacity of an erythropoietin purification process.

  2011cites this paper
• Erythropoiesis-stimulating agents: development, detection and dangers.

  2009cites this paper
• PCR assembly of synthetic human erythropoietin gene

  2009cites this paper
• Developments in the therapeutic use of erythropoiesis stimulating agents

  2008cites this paper
• Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations

  2008cites this paper
• Characterization of proteins involved in differentiation and apoptosis of human leukemia and epithelial cancer cells

  2008cites this paper
• Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma

  2007cites this paper
• Recombinant EPO production--points the nephrologist should know.

  2007cites this paper
• Capillary electrophoresis for the analysis of glycoprotein pharmaceuticals

  2006cites this paper
• Therapeutic implications of recombinant human erythropoietin in anaemic related clinical manifestations

  2006cites this paper
• Biomedicine and the Human Condition: Learning to Breed Successfully

  2005cites this paper
• Semisynthesis of human ghrelin: Condensation of a Boc‐protected recombinant peptide with a synthetic O‐acylated fragment

  2005cites this paper
• Biomedicine and the Human Condition: Fighting Infection

  2005cites this paper
• Biomedicine and the Human Condition: Challenges, Risks, and Rewards

  2005cites this paper
• Biomedicine and the Human Condition: Refurbishing the Body

  2005cites this paper
• Biomedicine and the Human Condition: Discovering Medicines: Infinite Variety through Chemistry

  2005cites this paper
• Biomedicine and the Human Condition: Epilogue: Signposts to “Wonderland”

  2005cites this paper
• Biomedicine and the Human Condition: Are Devastating Epidemics Still Possible?

  2005cites this paper
• Biomedicine and the Human Condition: Preface

  2005cites this paper
• Biomedicine and the Human Condition: Experiences in Utero Affect Later Life

  2005cites this paper
• Biomedicine and the Human Condition: How Life is Handed On

  2005cites this paper
• Biomedicine and the Human Condition: Cells in Sickness and Health

  2005cites this paper
• Biomedicine and the Human Condition: Signs of Ageing: When Renovation Slows

  2005cites this paper
• Biomedicine and the Human Condition: Cancer and the Body Plan: A Darwinian Struggle

  2005cites this paper
• Biomedicine and the Human Condition: References

  2005cites this paper
• Biomedicine and the Human Condition: Living with the Genetic Legacy

  2005cites this paper
• Biomedicine and the Human Condition: Infection, Nutrition, and Poisons: Avoiding an Unhealthy Life

  2005cites this paper
• Biomedicine and the Human Condition: Protein Medicines from Gene Technology

  2005cites this paper
• Epoetin alfa: basic biology and clinical utility in cancer patients

  2005cites this paper
• Biomedicine and the Human Condition: Challenges, Risks, and Rewards: Learning to Control Our Biological Fate

  2005cites this paper
• Biomedicine and the Human Condition

  2004cites this paper
• Molecular biology of erythropoietin.

  2004cites this paper
• Anemia in intensive care units

  2004cites this paper
• Production et glycosylation d'EPO par cellules CHO : caractérisation par électrophorèse capillaire au cours de procédés discontinus

  2003cites this paper
• Recombinant erythropoietin in clinical practice

  2003cites this paper
• Medical biotechnology in India.

  2003cites this paper
• Monitoring of the tissue distribution of fibroblast growth factor containing a high mannose-type sugar chain produced in mutant yeast

  2003cites this paper
• Monitoring biodistribution of glycoproteins with modified sugar chains.

  2003cites this paper
• Two‐dimensional electrophoresis of recombinant human erythropoietin: A future method for the European Pharmacopoeia?

  2002cites this paper
• Chinese Hamster Ovary Cells, Recombinant Protein Production

  2002cites this paper
• Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin (rhEPO)

  2002cites this paper
• Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties.

  2000cites this paper
• Efficient production of recombinant human erythropoietin by replenishment of microcarriers in the hollow fiber culture cassette.

  1999cites this paper